Aveanna Healthcare Holdings Inc. (AVAH)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Is Aveanna Healthcare (AVAH) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Aveanna Healthcare (AVAH) is a Great Momentum Stock to Buy
Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Fast-paced Momentum Stock Aveanna (AVAH) Is Still Trading at a Bargain
Aveanna (AVAH) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Is Aveanna Healthcare (AVAH) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Aveanna Healthcare Holdings Inc. (AVAH) Q3 2025 Earnings Call Transcript
Aveanna Healthcare Holdings Inc. ( AVAH ) Q3 2025 Earnings Call November 6, 2025 10:00 AM EST Company Participants Debbie Stewart - Senior VP & Principal Accounting Officer Jeffrey Shaner - CEO & Director Matt Buckhalter - CFO & Principal Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank AG, Research Division Brian Tanquilut - Jefferies LLC, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Raj Kumar - Stephens Inc., Research Division Albert Rice - UBS Investment Bank, Research Division Andrew Mok - Barclays Bank PLC, Research Division John Ransom - Raymond James & Associates, Inc., Research Division Michael Murray David MacDonald - Truist Securities, Inc., Research Division Presentation Debbie Stewart Senior VP & Principal Accounting Officer Good morning, and welcome to Aveanna's third quarter 2025 earnings call. I am Debbie Stewart, the company's Chief Accounting Officer.
Here's What Key Metrics Tell Us About Aveanna (AVAH) Q3 Earnings
The headline numbers for Aveanna (AVAH) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Despite Fast-paced Momentum, Aveanna (AVAH) Is Still a Bargain Stock
Aveanna (AVAH) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Aveanna (AVAH) Is Attractively Priced Despite Fast-paced Momentum
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Aveanna (AVAH) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Should You Buy Aveanna Healthcare (AVAH) After Golden Cross?
Aveanna Healthcare Holdings Inc. (AVAH) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, AVAH's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
Aveanna Healthcare Holdings Inc. (AVAH) Hit a 52 Week High, Can the Run Continue?
Aveanna (AVAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Earnings Estimates Rising for Aveanna (AVAH): Will It Gain?
Aveanna Healthcare (AVAH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
What Makes Aveanna Healthcare (AVAH) a Strong Momentum Stock: Buy Now?
Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
